This FSS contract for Pharmaceuticals > Pharmaceutical Products was awarded in FY2021 on March 29, 2021 to AIMMUNE THERAPEUTICS, INC. by National Acquisition Center. There have been $13.1k in obligations to date with a ceiling value of $500k, showing a 3% burn rate so far on the contract. The contract was not competed under any preference program with 999 offers received. We expect a 3 year duration with ultimate completion date of April 13, 2024.
AIMMUNE THERAPEUTICS, INC. is a contractor located in CA, doing primarily Pharmaceuticals > Pharmaceutical Products work for Veterans Affairs. Also, they have shown success winning No/Limited Bias contracts concentrated mainly on a singular customer focused portfolio.
The General Services Administration (GSA), the central acquisition entity within the Federal Government, manages a catalog of Multiple Award Schedules (MAS). The GSA uses MAS to establish lines of business or cohorts of contractors grouped by similar goods and services. Schedules are open to all government customers and provide a streamlined process to procure various professional services, IT services, and products, ranging from cars to hardware.
Imagine a world where every report, every insight is tailored specifically to you. Our entire platform is configured around your past performance so that everything is relevant.
We start with the largest federal opportunity database, including forecasts and re-competes, and add layer a suite of pipeline management tools.
Our market-centric platform adds context to every pursuit. Every opportunity, every report, tailored specifically to you.
Find gaps in the market, identify key competitors and teaming partners, evaluate performance, and analyze pathways to new business.
Federal Compass is software designed for today’s federal market.
Explore how the right intel and process can help lead your team to greater success.
Enjoy instant access to the Federal Compass platform
|Task Order No.||Contractor||Obligations||Effective Date|
|36C26024F0075||AIMMUNE THERAPEUTICS, INC.||$13.1k||11/07/2023|